1. Home
  2. NAMS vs AMBP Comparison

NAMS vs AMBP Comparison

Compare NAMS & AMBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • AMBP
  • Stock Information
  • Founded
  • NAMS 2019
  • AMBP 2021
  • Country
  • NAMS Netherlands
  • AMBP Luxembourg
  • Employees
  • NAMS N/A
  • AMBP N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • AMBP Containers/Packaging
  • Sector
  • NAMS Health Care
  • AMBP Industrials
  • Exchange
  • NAMS Nasdaq
  • AMBP Nasdaq
  • Market Cap
  • NAMS 1.7B
  • AMBP 1.9B
  • IPO Year
  • NAMS N/A
  • AMBP N/A
  • Fundamental
  • Price
  • NAMS $25.50
  • AMBP $3.07
  • Analyst Decision
  • NAMS Strong Buy
  • AMBP Hold
  • Analyst Count
  • NAMS 6
  • AMBP 7
  • Target Price
  • NAMS $36.20
  • AMBP $3.85
  • AVG Volume (30 Days)
  • NAMS 1.4M
  • AMBP 1.4M
  • Earning Date
  • NAMS 02-06-2025
  • AMBP 02-20-2025
  • Dividend Yield
  • NAMS N/A
  • AMBP 13.07%
  • EPS Growth
  • NAMS N/A
  • AMBP N/A
  • EPS
  • NAMS N/A
  • AMBP N/A
  • Revenue
  • NAMS $33,594,000.00
  • AMBP $4,845,000,000.00
  • Revenue This Year
  • NAMS $129.49
  • AMBP $3.26
  • Revenue Next Year
  • NAMS N/A
  • AMBP $3.68
  • P/E Ratio
  • NAMS N/A
  • AMBP N/A
  • Revenue Growth
  • NAMS 78.77
  • AMBP 1.87
  • 52 Week Low
  • NAMS $10.50
  • AMBP $2.98
  • 52 Week High
  • NAMS $27.29
  • AMBP $4.26
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 62.30
  • AMBP 24.89
  • Support Level
  • NAMS $24.40
  • AMBP $2.98
  • Resistance Level
  • NAMS $26.95
  • AMBP $3.18
  • Average True Range (ATR)
  • NAMS 1.66
  • AMBP 0.10
  • MACD
  • NAMS 0.41
  • AMBP -0.04
  • Stochastic Oscillator
  • NAMS 81.51
  • AMBP 10.49

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About AMBP Ardagh Metal Packaging S.A.

Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.

Share on Social Networks: